NeuroOne Medical Technologies Corporation Key Metrics

2 years of history · ending 2025-09-30 · SEC EDGAR

Forensics

Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.

F-Score (Piotroski 0-9)

Z-Score (Altman; <1.81 = distress)

Per Share Metrics

Turnover & Efficiency Analysis (days)

Expense Ratios

Working Capital Analysis

Valuation Multiples

Enterprise Value Multiples

52-Week Range

Trailing Returns

ROIC vs WACC

Yields

Capital Deployment Yields

EPS (Diluted)
$-0
Book Value Per Share
$0
Free Cash Flow Per Share
$-0
Cash Per Share
$0
Revenue Per Share
$0
OCF Per Share
$-0
Return on Equity
-91.3%
Return on Assets
-44.6%
Return on Invested Capital
-84.6%
Current Ratio
4.44
Quick Ratio
3.47
Asset Turnover
1.13
Days Sales Outstanding
50.74
Days Payables Outstanding
93.21
Days Inventory On Hand
205.44
Cash Conversion Cycle
162.97
R&D / Revenue
54.8%
SBC / Revenue
13.9%
Capex / Revenue
0.9%
Working Capital
$8M
Net Current Asset Value
$7M
Invested Capital
$7M
OCF / Net Income
0.79
FCF / Net Income
0.81
Accruals Ratio (Sloan)
-7.1%
Net Debt
$-7M
Net Debt / EBITDA
1.66
Interest Coverage
Cash Coverage
Capex Coverage
-34.71
Tangible Common Equity
$7M
TCE / Total Assets
65.2%
NOPAT
$-3M
Cash ROIC
-74.0%
WC / Revenue
87.1%
Capex / D&A
0.31
Reinvestment Rate
4.3%
Asset Growth vs Revenue Growth
-62.6%
Book Value 5Y CAGR
27.9%
Stock Price (FY-end)
$5
Market Cap
$214M
P/S Ratio
23.54
P/B Ratio
30.28
P/TB Ratio
30.48
Enterprise Value
$208M
EV / Sales
22.82
FCF Yield
-1.4%
Shareholder Yield
-0.6%
R&D Yield
2.3%
Capex Yield
0.0%
Shares Variation (YoY)
50.0%
Beta (5Y)
0.81
Cost of Equity
8.5%
52W High
$7
52W Low
$3
Trailing Return 1Y
-9.3%
Trailing Return 5Y
-78.0%
F-Score (Piotroski)
5.00
Z-Score (Altman)
24.84

Earnings Forecasts

Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).

Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.

EPS — Consensus vs Actual

Revenue — Consensus vs Actual

Stock Price on Earnings Dates